Arthritis Drugs Archive | 2006

Arthritis Drugs

Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.


Arthritis Drugs - Issue: 27

Health Canada Reports Remicade May Cause Rare, Aggressive Cancer

Read Full Article

California Jurors Find for Merck in State's First Vioxx Trial

Read Full Article

Judge Denies Merck Motion to Quash Subpoena for Vioxx MDL Trial

Read Full Article

N.J. Supreme Court to Hear Appeal of National Vioxx Class Certification

Read Full Article

Court Reverses Venue Ruling, Orders Transfer of Vioxx Class Action

Read Full Article

Merck Seeks to Bifurcate Damage Phases for Second Federal Vioxx Trial

Read Full Article



Arthritis Drugs - Issue: 26

Arthritis Drugs in the Medical Literature This Month - July 2006

Read Full Article



Arthritis Drugs - Issue: 27

Survey: Patients Wary of Seeking Pain Relief Due to Drug Safety Concerns

Read Full Article




ISSUES BY YEAR




The HarrisMartin VerdicTrack



The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.